World Health Organization Issues Concern Over Critical Shortage of Obesity Jabs

Less than one in 10 individuals eligible to benefit from obesity jabs such as Wegovy are able to get them, caution the WHO as it issues its first recommendations on the drugs.

With over a billion individuals worldwide now classified as obese, it is advocating for more widespread and fairer availability to these injectable treatments.

According to projections, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.

"Our latest guidance acknowledges that excess weight is a chronic disease that can be treated with thorough and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and supply-chain constraints are major barriers to widespread access to the injections that can aid individuals in losing substantial body mass, says the agency.

Weight-Loss Drug Scarcity

Even under the current most favorable case, the supply of such drugs would only suffice for around 100 million people – fewer than 10% of eligible patients, as stated by the health organization.

The recommendation calls on governments and firms to expand access, by strategies like patent sharing.

The intellectual property rights on a key compound – the primary ingredient of the drug Wegovy – is scheduled to end in a number of countries in 2026.

How Weight-Loss Jabs Operate

The injections imitate a biological compound to delay gastric emptying, reduce hunger and boost feelings of fullness so people reduce food intake.

Individuals usually start to lose weight after several weeks of beginning the regular doses.

Studies suggests people may see weight return a year later of discontinuing the medication, when their usual food cravings resume.

Being carrying excess weight raises your likelihood for developing diseases, like diabetes, cardiovascular issues, stroke, and certain cancers.

Excess weight impacts people in all nations and was linked to over three and a half million fatalities worldwide in 2024, per the WHO.